» Authors » Dewan Md Sakib Hossain

Dewan Md Sakib Hossain

Explore the profile of Dewan Md Sakib Hossain including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 19
Citations 1098
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Sakib Hossain D, Panda A, Manna A, Mohanty S, Bhattacharjee P, Bhattacharyya S, et al.
Immunity . 2021 Sep; 54(9):2167. PMID: 34525341
No abstract available.
2.
Galluzzi L, Vitale I, Warren S, Adjemian S, Agostinis P, Buque Martinez A, et al.
J Immunother Cancer . 2020 Mar; 8(1). PMID: 32209603
Cells succumbing to stress via regulated cell death (RCD) can initiate an adaptive immune response associated with immunological memory, provided they display sufficient antigenicity and adjuvanticity. Moreover, multiple intracellular and...
3.
Sakib Hossain D, Javaid S, Cai M, Zhang C, Sawant A, Hinton M, et al.
J Clin Invest . 2018 Jan; 128(2):644-654. PMID: 29337311
Blockade of the checkpoint inhibitor programmed death 1 (PD1) has demonstrated remarkable success in the clinic for the treatment of cancer; however, a majority of tumors are resistant to anti-PD1...
4.
Zhang Q, Sakib Hossain D, Duttagupta P, Moreira D, Zhao X, Won H, et al.
Blood . 2016 Jan; 127(13):1687-700. PMID: 26796361
Targeting oncogenic transcription factor signal transducer and activator of transcription 3 (STAT3) in acute myeloid leukemia (AML) can reduce blast survival and tumor immune evasion. Decoy oligodeoxynucleotides (dODNs), which comprise...
5.
Sakib Hossain D, Moreira D, Zhang Q, Nechaev S, Swiderski P, Kortylewski M
Methods Mol Biol . 2015 Oct; 1364:183-96. PMID: 26472451
The SiRNA strategy is a potent and versatile method for modulating expression of any gene in various species for investigational or therapeutic purposes. Clinical translation of SiRNA-based approaches proved challenging,...
6.
Sakib Hossain D, Duttagupta P, Kortylewski M
Ther Deliv . 2015 Jan; 6(1):1-4. PMID: 25565435
No abstract available.
7.
Pal S, Sakib Hossain D, Zhang Q, Frankel P, Jones J, Carmichael C, et al.
J Urol . 2014 Oct; 193(4):1114-21. PMID: 25286010
Purpose: Pazopanib has been assessed primarily in cytokine refractory or treatment naïve patients with metastatic renal cell carcinoma. Outcomes have been associated with a specific immunological profile. However, pazopanib activity...
8.
Sakib Hossain D, Panda A, Manna A, Mohanty S, Bhattacharjee P, Bhattacharyya S, et al.
Immunity . 2013 Dec; 39(6):1057-69. PMID: 24315995
This article has been retracted: please see Elsevier Policy on Article Withdrawal (http://www.elsevier.com/locate/withdrawalpolicy). This article has been retracted at the request of the authors. This study provided an explanation for...
9.
Sakib Hossain D, Dos Santos C, Zhang Q, Kozlowska A, Liu H, Gao C, et al.
Blood . 2013 Oct; 123(1):15-25. PMID: 24169824
Signal transducer and activator of transcription 3 (STAT3) is an oncogene and immune checkpoint commonly activated in cancer cells and in tumor-associated immune cells. We previously developed an immunostimulatory strategy...
10.
Saha S, Sakib Hossain D, Mukherjee S, Mohanty S, Mazumdar M, Mukherjee S, et al.
BMC Complement Altern Med . 2013 Sep; 13:230. PMID: 24053127
Background: Complementary medicines, including homeopathy, are used by many patients with cancer, usually alongside with conventional treatment. However, the molecular mechanisms underneath the anti-cancer effect, if any, of these medicines...